Lv1
74 积分 2022-01-04 加入
The 2026 Wakley–Wu Lien Teh Prize Essay: why medicine, and why stay?
8天前
已完结
Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study
1个月前
已完结
Hematopoietic-Cell Transplantation at 50
1个月前
已完结
Navigating the Post‐ BCMA / GPRC5D Landscape: Efficacy of Selinexor, Bortezomib, and Dexamethasone After Sequential Immunotherapy Failure in Penta‐Refractory Multiple Myeloma—A Multicenter Analysis
1个月前
已完结
The Care and Cure of the Leukemias in 2026
2个月前
已完结
Oesophageal cancer
3个月前
已完结
Treatment of NSCLC after chemoimmunotherapy — are we making headway?
3个月前
已完结
Sevabertinib in Advanced HER2 -Mutant Non–Small-Cell Lung Cancer
5个月前
已完结
Time-of-day immunochemotherapy in nonsmall cell lung cancer: a randomized phase 3 trial
5个月前
已完结
Sevabertinib in Advanced HER2 -Mutant Non–Small-Cell Lung Cancer
5个月前
已完结
皖公网安备34019202002308
